Armata Pharmaceuticals, Inc. (ARMP)
5.77
+0.25
(+4.53%)
USD |
NYAM |
Sep 04, 13:15
Armata Pharmaceuticals PE Ratio
PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical PE Ratio Data
| Date | Value |
|---|---|
| September 29, 2015 | 0.0265 |
| September 28, 2015 | 0.0281 |
| September 25, 2015 | 0.0305 |
| September 24, 2015 | 0.0339 |
| September 23, 2015 | 0.036 |
| September 22, 2015 | 0.0369 |
| September 21, 2015 | 0.0392 |
| September 18, 2015 | 0.0385 |
| September 17, 2015 | 0.0437 |
| September 16, 2015 | 0.0437 |
| September 15, 2015 | 0.0436 |
| September 14, 2015 | 0.0437 |
| September 11, 2015 | 0.0443 |
| September 10, 2015 | 0.0441 |
| Date | Value |
|---|---|
| September 09, 2015 | 0.0446 |
| September 08, 2015 | 0.0459 |
| September 04, 2015 | 0.0418 |
| September 03, 2015 | 0.0411 |
| September 02, 2015 | 0.0424 |
| September 01, 2015 | 0.0427 |
| August 31, 2015 | 0.0428 |
| August 28, 2015 | 0.0412 |
| August 27, 2015 | 0.0425 |
| August 26, 2015 | 0.043 |
| August 25, 2015 | 0.0456 |
| August 24, 2015 | 0.0468 |
| August 21, 2015 | 0.0478 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| Agenus, Inc. | 3.131 |
| Amgen, Inc. | 27.14 |
| Anika Therapeutics, Inc. | -- |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | -- |
PE Ratio Related Metrics
| PS Ratio | 44.54 |
| PEG Ratio | -0.0008 |
| Price | 5.77 |
| Earnings Yield | -131.5% |
| Market Cap | 214.33M |
| PEGY Ratio | -0.0008 |